EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 17 filers reported holding EVOKE PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $183,000 | -29.1% | 100,000 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $258,000 | -45.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $469,000 | +32.5% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $354,000 | +205.2% | 100,000 | 0.0% | 0.00% | – |
| Q1 2020 | $116,000 | -28.4% | 100,000 | 0.0% | 0.00% | – |
| Q4 2019 | $162,000 | +88.4% | 100,000 | 0.0% | 0.00% | – |
| Q3 2019 | $86,000 | +36.5% | 100,000 | 0.0% | 0.00% | – |
| Q2 2019 | $63,000 | -58.0% | 100,000 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $150,000 | -39.5% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $248,000 | -16.8% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $298,000 | +19.2% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $250,000 | +20.2% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $208,000 | -8.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $226,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wambolt & Associates, LLC | 32,000 | $150,000 | 0.11% |
| SABBY MANAGEMENT, LLC | 22,382 | $105,000 | 0.02% |
| Cetera Advisor Networks LLC | 30,260 | $142,000 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 32,387 | $151,000 | 0.00% |
| Creative Planning | 100,000 | $469,000 | 0.00% |
| Dorsey Wright & Associates | 1,604 | $8,000 | 0.00% |
| Lindbrook Capital, LLC | 1,000 | $5,000 | 0.00% |
| NORTHERN TRUST CORP | 37,227 | $175,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 10,057 | $47,000 | 0.00% |